Best Hospitals for Pelvic Adhesiolysis in Hyderabad, India

In India, laparoscopic pelvic adhesiolysis at a JCI- or NABH-accredited hospital typically costs between USD 1,500 and USD 4,500, depending on surgical complexity, the need for robotic assistance (da Vinci platform), concurrent procedures such as endometriosis excision or salpingolysis, the tier of hospital selected, and the city of treatment (Mumbai, Delhi, Chennai, and Hyderabad are the primary hubs). This cost generally includes the surgeon's fee, anaesthetist's fee, operating theatre charges, 1–3 nights of hospital stay, post-operative medications, and standard nursing care. In the UAE (Dubai or Abu Dhabi), equivalent treatment at a JCI-accredited or DHA-licensed hospital costs between USD 3,500 and USD 9,000, reflecting higher hospital overheads, premium infrastructure, and the cost of living in the UAE. For patients with complex or recurrent adhesive disease requiring robotic surgery and extended hospital stay, costs at the upper end of both ranges apply. India is consistently 40–60% more affordable than the UAE for equivalent surgical expertise and accreditation standards, making it the preferred destination for cost-conscious patients. GAF Healthcare provides a detailed, itemised cost estimate for your specific case before you commit to travel — contact our case management team with your medical records for a personalised quote.

The minimum safe stay before an international flight depends on the surgical approach used. For laparoscopic pelvic adhesiolysis — the most common and minimally invasive technique — most patients are cleared for long-haul air travel at 10–14 days post-operatively, provided they meet all discharge criteria: no fever, satisfactory wound healing, pain controlled on oral analgesics, and normal bowel and bladder function. For robotic-assisted laparoscopic adhesiolysis the recovery timeline is similar. For open (laparotomy) adhesiolysis — reserved for complex or emergency cases — the fit-to-fly period extends to 3–4 weeks post-operatively, as abdominal wall healing must be sufficient to tolerate cabin pressure changes and prolonged immobility. Your operating surgeon will issue a formal fitness-to-fly certificate at the Day 10–14 or Day 21–28 review appointment, which is required by most airlines for post-surgical passengers. GAF Healthcare schedules this review as part of your care package and arranges your accommodation in India or the UAE for the full recovery period, ensuring you do not have to travel prematurely. All patients are advised to wear graduated compression stockings and perform hourly in-seat leg exercises during the return flight to minimise DVT risk.

The success rate of pelvic adhesiolysis depends on the primary indication, surgical technique, adhesion severity (classified by the Peritoneal Adhesion Index/PAI or AFS scoring system), and whether an anti-adhesion barrier is used. For chronic pelvic pain relief, laparoscopic adhesiolysis achieves significant symptomatic improvement in 70–85% of patients at 12 months post-operatively, with robotic-assisted cases at experienced centres reporting outcomes at the higher end of this range. For infertility as the primary indication, clinical pregnancy rates of 30–45% within 12 months of surgery have been reported in patients with tubo-ovarian adhesions as the sole or dominant infertility factor, rising to 50–60% when combined with IVF where tubal damage is irreversible. The most important limitation is adhesion recurrence: despite meticulous surgical technique and the use of anti-adhesion barriers (Seprafilm, Adept/icodextrin 4%), adhesion reformation occurs in 40–60% of patients within 12 months and in up to 85% within 3 years, with symptomatic recurrence requiring re-intervention in approximately 20–30% of cases. Post-operative hormonal suppression (GnRH agonists, progesterone, or combined oral contraceptives) in endometriosis-related cases significantly reduces the risk of symptomatic recurrence. GAF Healthcare partner hospitals are high-volume centres where surgeons perform over 150 pelvic adhesiolysis procedures annually, a factor strongly correlated with better outcomes, lower complication rates, and reduced recurrence in the peer-reviewed literature.